[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352247-105":59,"doc-detail-352247-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","tumour-associated-muc1-exerts-multiple-effects-on-cholesterol-and-lipid-metabolism-a-potential-pathogenic-effector-of-atherosclerosis-in-cancer","Tumour-Associated MUC1 Exerts Multiple Effects on Cholesterol and Lipid Metabolism - A Potential Pathogenic Effector of Atherosclerosis in Cancer","","Cancer contributes to atherosclerosis progression, while inflammatory features of atherosclerotic disease can profoundly influence cancer development and outcomes. Tumour-associated Mucin 1 (TA-MUC1), a transmembrane glycoprotein overexpressed in intestinal epithelial cancers, is linked to altered cholesterol handling. Using MUC1 knockdown breast cancer cells and co-culture models, TA-MUC1 was tested for effects on cholesterol and lipid metabolism and for signaling changes driving aberrant lipid processes. TA-MUC1 activity reduction altered multiple relevant pathways and induced foam-cell differentiation. Targeting TA-MUC1 with an anti-MUC1 antibody reduced its cholesterol-metabolism effects, suggesting therapeutic relevance for cancer-associated atherosclerosis.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumour-associated-muc1-exerts-multiple-effects-on-cholesterol-and-lipid-metabolism-a-potential-pathogenic-effector-of-atherosclerosis-in-cancer/352247/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumour-associated-muc1-exerts-multiple-effects-on-cholesterol-and-lipid-metabolism-a-potential-pathogenic-effector-of-atherosclerosis-in-cancer/352247.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is TA-MUC1 and why is it relevant to atherosclerosis in cancer?","Question",{"text":112,"@type":113},"TA-MUC1 is a transmembrane glycoprotein overexpressed in epithelial cancers. The article proposes that TA-MUC1 can influence cholesterol and lipid metabolism, thereby acting as a pathogenic effector in cancer-associated atherosclerosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TA-MUC1’s effect on cholesterol and lipid metabolism tested?",{"text":117,"@type":113},"The study used MUC1 gene knockdown breast cancer cells to assay effects on cholesterol metabolism. It also employed an in vitro co-culturing model to assess impacts on other cells under conditions similar to in vivo biology.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens when TA-MUC1 activity is reduced or inhibited?",{"text":121,"@type":113},"Reduction or inhibition of TA-MUC1 significantly altered multiple signaling pathways and proteins associated with abnormal cholesterol metabolism. Co-culturing TA-MUC1 cancer cells with THP-1 cells promoted monocytic THP-1 differentiation toward foam cells.",{"name":123,"@type":110,"acceptedAnswer":124},"How might anti-MUC1 therapy affect cholesterol metabolism?",{"text":125,"@type":113},"The article reports that a therapeutic anti-MUC1 antibody reduced the effect of TA-MUC1 on cholesterol metabolism. Targeting TA-MUC1-mediated cholesterol modulation may benefit cancer patients who also have atherosclerosis.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},352247,1790882768,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":31,"preview_page_count":19,"preview_urls":148},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Article  \nTumour-Associated MUC1 Exerts Multiple Effects on Cholesterol and Lipid Metabolism—A Potential Pathogenic Effector of Atherosclerosis in Cancer  \nYunliang Chen * and Michael Scully  \nAcademic Editors: Tzong-Shyuan Lee and David Della-Morte  \nReceived: 30 September 2025  \nRevised: 17 December 2025  \nAccepted: 27 December 2025  \nPublished: 4 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nThrombosis Research Institute, London SW3 6LR, UK  \n* [Correspondence: ychen@tri-london.ac.uk](Correspondence: ychen@tri-london.ac.uk)  \nAbstract  \n(1) Cancer has been shown to contribute to the progression of atherosclerosis, while inflammatory aspects of atherosclerosis can exert profound effects on cancer development and outcomes. TA-MUC1 (Tumour-associated Mucin 1) is a transmembrane glycoprotein that is overexpressed in many human epithelial cancers lining the intestine. Interestingly, the lack of intestinal MUC1 has been shown to impair cholesterol uptake in MUC1−/ − mice.  \n(2) To investigate whether TA-MUC1 could have specific effects on cholesterol metabolism and, thereby, have the potential of impacting the pathogenesis of atherosclerosis in cancer patients. (3) The effect of TA-MUC1 on cholesterol and lipid metabolism was assayed using MUC1 gene knock down breast cancer cells. An in vitro coculturing model similar to in vivo biological conditions was used to determine that TA-MUC1 could also modulate the cholesterol metabolism of other cells. (4) Reduction or inhibition of TA-MUC1 activity resulted in a significant alteration in a number of the signalling pathways and proteins that are relevant to abnormal cholesterol metabolism (p \u003C 0.0001) . Coculturing of TA-MUC1 cancer cells with THP-1 cells also notably effectively induced monocytic THP-1 cell differentiation towards foam cells—foam cells being a characteristic feature of atherosclerotic blood vessels. (5) Previously, we found TA-MUC1 downregulation led to a reduction in procoagulant and prothrombotic properties of the cancer cells as well as modulation of the aberrant calcium signalling pathways of cancer cells. Taken together with these current results, this suggests that TA-MUC1 in cancer cells has multiple effects on cholesterol and lipid metabolism, which also impacts other cells in the cellular bioenvironment. TA-MUC1 could thereby act as an important pathogenic effector of atherosclerosis in cancer. These results can also be considered in respect of the therapeutic anti-MUC1 antibody, which was able to reduce the effect of TA-MUC1 on cholesterol metabolism. Modulation of cholesterol metabolism via targeting TA-MUC1 could, therefore, be of great benefit to cancer patients with atherosclerosis.  \nKeywords: tumour-associated MUC1 (TA-MUC1); atherosclerosis; cancer; cholesterol and lipid metabolism; foam cells  \n1. Introduction  \nAtherosclerosis and cancer are chronic diseases considered as two of the main causes of death all over the world. Both diseases arise from multiple factors during different stages in their development but also share common risk factors, comprising genetic alterations, inflammatory processes, uncontrolled cell proliferation, angiogenesis, apoptosis and oxidative stress, during the course of growth dysregulation. This dysregulation involves not  \nonly several important molecular pathways but also many aetiological and mechanistic processes from the very early stages of development up to the advanced stages in both pathologies [1,2] .  \nIt is well known that cancer may promote atherosclerosis and change the functional and structural markers of subclinical atherosclerosis [3] . Patients with cancer have a high prevalence of atherosclerosis, which may be related to the systemic inflammatory response and impaired vascular endothelial function caused by the mechanism of cancer ","cbCaiq6ubkgVCwIq","https://ap.wps.com/l/cbCaiq6ubkgVCwIq","pdf",2903671,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What is TA-MUC1 and why is it relevant to atherosclerosis in cancer?\",\"answer\":\"TA-MUC1 is a transmembrane glycoprotein overexpressed in epithelial cancers. The article proposes that TA-MUC1 can influence cholesterol and lipid metabolism, thereby acting as a pathogenic effector in cancer-associated atherosclerosis.\"},{\"question\":\"How was TA-MUC1’s effect on cholesterol and lipid metabolism tested?\",\"answer\":\"The study used MUC1 gene knockdown breast cancer cells to assay effects on cholesterol metabolism. It also employed an in vitro co-culturing model to assess impacts on other cells under conditions similar to in vivo biology.\"},{\"question\":\"What happens when TA-MUC1 activity is reduced or inhibited?\",\"answer\":\"Reduction or inhibition of TA-MUC1 significantly altered multiple signaling pathways and proteins associated with abnormal cholesterol metabolism. Co-culturing TA-MUC1 cancer cells with THP-1 cells promoted monocytic THP-1 differentiation toward foam cells.\"},{\"question\":\"How might anti-MUC1 therapy affect cholesterol metabolism?\",\"answer\":\"The article reports that a therapeutic anti-MUC1 antibody reduced the effect of TA-MUC1 on cholesterol metabolism. Targeting TA-MUC1-mediated cholesterol modulation may benefit cancer patients who also have atherosclerosis.\"}]","Tumour-Associated MUC1 Exerts Multiple Effects on Cholesterol and Lipid Metabolism - A Potential Pathogenic Effector of Atherosclerosis in Cancer | PDF",1790098546,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/385000c4742ba1a415affe390c4ec618.webp",983,1390,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e6130e434c71225e8033e02bd9f780b.webp",982,1388,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9f35b46fd51694d8431461b35ecb6ed.webp",981,1387,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1db66e0758525086566079730ac0f383.webp",980,1385]